Neogene Therapeutics
  • About Us
    • Our Mission
    • Our History
    • Our Team
  • Our Science
  • News/Events
  • Careers
  • Contact
Menu
  • About Us
    • Our Mission
    • Our History
    • Our Team
  • Our Science
  • News/Events
  • Careers
  • Contact
News/Events

Neogene Therapeutics Announces Approval of Clinical Trial Application for its First Phase 1 Trial of Novel, Fully-Individualized TCR Therapy to Treat Advanced Solid Tumors

May 10, 2022
Read More >

Neogene Therapeutics Announces Exclusive License with the National Cancer Institute for a Portfolio of T Cell Receptors (TCR) Targeting KRAS and TP53 Mutations for the Treatment of Cancer

January 11, 2022
Read More >

Neogene Therapeutics Appoints Raphaël Rousseau, M.D., Ph.D., as Chief Medical Officer

December 16, 2021
Read More >

Neogene Therapeutics Appoints Han Lee, Ph.D., MBA, as Chief Financial Officer

September 14, 2021
Read More >

Neogene Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA as Chief Operating Officer

May 26, 2021
Read More >

Neogene Therapeutics Announces Ton Schumacher, Ph.D., Company Co-Founder, Awarded 2021 Jeantet-Collen Prize for Translational Medicine

January 26, 2021
Read More >

Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies

October 13, 2020
Read More >

Neogene Therapeutics Appoints Former Roche Chairman and Chief Executive Officer Franz B. Humer, Ph.D., as Executive Chairman of Board of Directors

October 6, 2020
Read More >

Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies

September 14, 2020
Read More >
White Neogene Logo
  • About Us
    • Our Mission
    • Our History
    • Our Team
  • Our Science
  • News/Events
  • Careers
  • Contact
Menu
  • About Us
    • Our Mission
    • Our History
    • Our Team
  • Our Science
  • News/Events
  • Careers
  • Contact
  • Linkedin
Register for Updates

US Headquarters

Neogene Therapeutics, Inc.
2225 Colorado Blvd
Santa Monica, CA 90404
United States

EU Headquarters

Neogene Therapeutics, B.V.
Science Park 106
1098 XG Amsterdam
The Netherlands

©2021 Neogene Therapeutics. Visit our cookie policy.

Privacy Notice

Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}